Skip to main content
SpringerLink
Log in

Thromboembolic complications associated with brain tumors

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Thromboembolic complications are the second most common cause of death in hospitalized cancer patients; they are caused by alterations of hemostasis and include hypercoagulable states, acute and chronic disseminated intravascular coagulation, and primary fibrinolysis. The fibrinolytic system is comprised of several serine protease enzymes and their inhibitors and is associated in various biological systems with physiological and pathological events such as tissue development, remodeling, invasiveness, and migratory potentials of both normal and malignant cells. It also plays a key role in the dissolution of fibrin strands. Defective fibrinolysis, which is often associated with the pathogenesis of venous thrombosis and other thromboembolic complications, occurs when the balance is disrupted, resulting in either inhibition or enhancement of fibrinolysis. The association between thromboembolic complications and neoplastic disease has been well-established since Trousseau in 1865 first reported a high incidence of venous thrombosis in a series of patients with gastric carcinoma. In this article, we discuss the factors that have been shown to be associated with thromboembolic complications in patients who harbor brain tumors, namely, hemostatic alterations caused by the tumors themselves or through interactions with neural tissue around the tumors, pre-operative hemostatic alterations in certain patients, and defective fibrinolysis associated with specific tumor types and/or tumor locations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bergsdorf N, Nilsson T, Wallen P: An enzyme linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease. Thromb Haemost 50: 740–744, 1983

    PubMed  Google Scholar 

  2. Al-Mondhiry H: Disseminated intravascular coagulation experience in a major cancer center. Thromb Diath Haemorrhage 34: 181–193, 1975

    Google Scholar 

  3. Morozov VV: Blood coagulation properties in patients with supratentorial tumors during pre- and post-operative periods. Zh Vopr Neirokhir 34: 56–60, 1970

    Google Scholar 

  4. Soong BCF, Miller SP: Coagulation disorders in cancer III. Fibrinolysis and inhibitors. Cancer 25: 867–874, 1970

    PubMed  Google Scholar 

  5. Rasche H, Dietrich M: Hemostatic abnormalities associated with malignant diseases. Eur J Cancer 13: 1053–1064, 1977

    PubMed  Google Scholar 

  6. Rickles FR, Edwards RL: Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 62: 14–31, 1983. Trousseau A: Plegmasia Alba Dolens, Clinique Medicale de l'Hotel Dieu de Paris. Paris, Balliere, 1865, vol 3, pp 94–96 and 654–1062, 1865

    PubMed  Google Scholar 

  7. Rickles FR, Edwards RL, Barb Cet al.: Abnormalities of blood coagulation in patients with cancer. Cancer 51: 301–307, 1983

    PubMed  Google Scholar 

  8. Sawaya R, Highsmith R: Brain tumors and the fibrinolytic enzyme system. In: Kornblith PL, Walker MD (eds) Advances in Neuro-Oncology. Mount Kisco, HY, Futura, 1988, p 103–157

    Google Scholar 

  9. Patrassi GM, Sartori MT, Viero MLet al.: The fibrinolytic potential in patients with Cushing's disease: A clue to their hypercoagulable state. Blood Coagul Fibrin 3: 789–793, 1992

    Google Scholar 

  10. Sawaya R, Ramo OJ: Systemic and thromboembolic effects of meningioma. In: Al-mefty O (ed) Meningiomas. New York, Raven Press, Ltd, 1991, p 137–144

    Google Scholar 

  11. Petaja J, Rasi V, Myllyla G: Familial hypofibrinolysis and venous thrombosis. Br J Haematol 71: 393–398, 1989

    PubMed  Google Scholar 

  12. Korninger C, Lechner K, Neissner N, Gøssinger H, Kundi M: Impaired fibrinolytic capacity predisposes for recurrence of venous thrombosis. Thromb Haemostas 52: 127–130, 1984

    Google Scholar 

  13. O'Connor NTJ, Cederholm-Williams SA, Fletcher EW, Allington M, Sharp AA: Significance of idiopathic deep venous thrombosis. Postgrad Med J 60: 275–277, 1984

    PubMed  Google Scholar 

  14. Samama MM: Hypofibrinolysis and venous thrombosis. In: Neri Serneri GG, Gensini GF, Abbate R, Prisco D (eds) Thrombosis: An update. Florence: Scientific Press, 1992, p 165–181

    Google Scholar 

  15. Patrassi GM, Sartori MT, Viero Met al.: Venous thrombosis and tissue plasminogen activator release deficiency: a family study. Blood Coag Fibrinol 2: 231–235, 1991

    Google Scholar 

  16. Sawaya R, Cummins CF, Kornblith PL: Brain tumors and plasmin inhibitors. Neurosurgery 15: 795–800, 1984

    PubMed  Google Scholar 

  17. Carrel A, Burrows MT: Cultivationin vitro of malignant tumors. J Exp Med 13: 571–575, 1911

    Google Scholar 

  18. Fischer A: The cultivation of malignant tumor cells indefinitely outside the body. J Cancer Res 9: 62–70, 1925

    Google Scholar 

  19. Unkeless JC, Tobia A, Ossowski Let al.: An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med 137: 85–111, 1973

    PubMed  Google Scholar 

  20. Ossowski L, Unkeless JC, Tobia Aet al.: A enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses. J Exp Med 137: 112–126, 1973

    PubMed  Google Scholar 

  21. Ng R, Kellen JA: The role of plasminogen activators in metastasis. Mee Hypotheses 10: 291–293, 1983

    Google Scholar 

  22. Nathanson M, Savitsky JP: Platelet adhesive index studies in multiple sclerosis and other neurological disorders. Bull NY Acad Med 23: 462–468, 1952

    Google Scholar 

  23. Wetzel N, Anderson MC, Shields TW: Pulmonary embolism as a cause of death in the neurosurgical patient. J Neurosurg 17: 664–668, 1960

    PubMed  Google Scholar 

  24. Millac P: Platelet stickiness in patients with intracranial tumours. Br Med J 4: 25–26, 1967

    PubMed  Google Scholar 

  25. Morozov VV: The coagulative and anticoagulative blood systems in cerebral tumors of a supratentorial localization. Zh Nevropat Psikhiat Korsakov 68: 505–509, 1968

    Google Scholar 

  26. MacGee EE, Bernell WR: Acute fibrinolysis following craniotomy and removal of metastatic tumor of the cerebellum. J Neurosurg 32: 578–580, 1970

    PubMed  Google Scholar 

  27. Vardi Y, Steifler M, Schujman E, Lowenthal M: Diffuse intravascular coagulation associated with a primary brain tumor. J Neurol Neurosurg Psychiatry 37: 987–990, 1974

    Google Scholar 

  28. Matjasha MJ, Ducker TB: Disseminated intravascular coagulation associated with removal of a primary tumor. Neurosurg 47: 476–480, 1977

    Google Scholar 

  29. Kayser-Gatchalian MC, Kayser K: Thrombosis and intracranial tumors. J Neurol 209: 207–224, 1975

    Google Scholar 

  30. Ruff RL, Posner JB: Incidence and treatment of peripheral venous thrombosis in patients with gliomas. Ann Neurol 334–336, 1983

  31. Bick RL: Alterations of hemostasis associated with malignancy: Etiology, pathophysiology, diagnosis and management. Semin Thromb Hemostas 5: 1–26, 1978

    Google Scholar 

  32. Didisheim P, Bowie EJ, Owen CA: Intravascular coagulation-fibrinolysis (ICF) syndrome and malignancy: Historical review and report of two cases with metastatic carcinoid and with acute myelomonocytic leukemia. Thromb Diath Haemorhag 36 (suppl): 215–231, 1969

    Google Scholar 

  33. Fountain JR, Holman RL: Acquired fibrinogen deficiency associated with carcinoma of the bronchus. Ann Intrn Med 52: 459–463, 1960

    Google Scholar 

  34. Hagedorn AB, Bowie EJW, Elveback LR, Owen CA: Coagulation abnormalities in patients with inoperable lung cancer. Mayo Clin Proc 49: 647–653, 1974

    PubMed  Google Scholar 

  35. Goodnight SC Jr: Bleeding and intravascular clotting in malignancy: A review. Ann NY Acad Sci 230: 271–288, 1974

    PubMed  Google Scholar 

  36. Edgington TS: Activation of the coagulation system in association with neoplasiz. J Lab Clin Med 96: 1–4, 1980

    PubMed  Google Scholar 

  37. Weinberg S, Phillips L, Twersky R, Cottrell JE, Braunstein KM: Hypercoagulability in a patient with a brain tumor. Anesthesiology 61: 200–202, 1984

    PubMed  Google Scholar 

  38. Sawaya R, Zuccarello M, Highsmith R: Alpha-1-antitrypsin in human brain tumors. J Neurosurg 67: 258–262, 1987

    PubMed  Google Scholar 

  39. Hurt JP, Odom MH, Perlmutt L, Krigman MK: Blood clotting changes in guinea pigs with hetrologous intracranial neoplasm. Lab Invest 23: 179–183, 1970

    PubMed  Google Scholar 

  40. Hince TA, Roscoe JP: Differences in pattern and level of plasminogen activator production between a cloned cell line from an ethylnitrosourea-induced glioma and one from normal adult rat brain. J Cell Physiol 104: 199–207, 1980

    PubMed  Google Scholar 

  41. Tovi D, Pandolfi M, Astedt B: Local haemostasia in brain tumours. Experientia 31: 977–978, 1975

    PubMed  Google Scholar 

  42. Sawaya R, Donlon JA: Chronic disseminated intravascular coagulation and metastatic brain tumor: A case report and review of the literature. Neurosurgery 12: 580–584, 1983

    PubMed  Google Scholar 

  43. Jamieson GA, Bastida E, Ordinas A: Mechanisms of platelet aggregation by human tumor cell lines. In: Jamieson GA (ed) Interaction of Platelets and Tumor Cells. New York, Alan R. Liss, 1982, pp 405–413

    Google Scholar 

  44. Dvorak HF, Senger DR, Dvorak AMet al.: Regulation of extravascular coagulation by microvascular permeability. Science 227: 1059–1061, 1985

    PubMed  Google Scholar 

  45. Higushi H: Tissue coagulation system and fibrinolytic activity of brain tumors. Neurol Med Chir 19: 509–516, 1979

    Google Scholar 

  46. Wilson EL, Dowdle E: Plasminogen activator secretion by normal and neoplastic human tissue culturesin vitro. In: Magnusson S, Ottesen M, Foltmann B, Dano K, Neurath H (eds) Regulatory Proteolytic Enzymes and Their Inhibitors. New York: Pergamon Press, 1977, vol 471, pp 151–161

    Google Scholar 

  47. Zanker KS, Stavrou D, Blumel G: Fibrin degradation products, produced by glioma cell-associated fibrinolysis and the partial inhibition of cell growth and migration in tissue culture. Cell Mol Biol 25: 387–394, 1979

    Google Scholar 

  48. Tucker WS, Kirsch WM, Martinez-Hernandez A, Fink LM:In vitro plasminogen activator activity in human brain tumors. Cancer Res 38: 297–302, 1978

    PubMed  Google Scholar 

  49. Wilson EL, Becker LB, Hoal EG, Dowdle EB: Molecular species of plasminogen activators secreted by normal and neoplastic human cells. Cancer Res 40: 933–938, 1980

    PubMed  Google Scholar 

  50. Bykowska K, Rijken DC, Collen D: Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture. Thromb Haemost 46: 642–644, 1981

    PubMed  Google Scholar 

  51. Nielson LS, Hansen JG, Skriver Let al.: Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry 21: 6410–6415, 1982

    PubMed  Google Scholar 

  52. Sawaya R, Highsmith R: Plasminogen activator activity and molecular weight patterns in human brain tumors. J Neurosurg 68 73–79, 1988

    PubMed  Google Scholar 

  53. Sawaya R, Zuccarello M, El-Kalliny M: Brain tumors and thromboembolism: Clinical hemostatic and biochemical correlation (abstract) AANS Meeting, Washington, DC < April 1989

  54. Zuccarello M, Sawaya R, Ray M: Immunohistochemical demonstration of alpha-1-proteinase inhibitor in brain tumors. Cancer 60: 804–809, 1987

    PubMed  Google Scholar 

  55. Kitchens CS: Concept of hypercoagulability: A review of its development, clinical application, and recent progress. Semin Thromb Hemost 11: 293–315, 1985

    PubMed  Google Scholar 

  56. Sawaya R, Glas-Greenwalt P: Postoperative venous thromboembolism and brain tumors: part II. Hemostatic profile. J Neuro-Oncol 14: 127–134, 1992

    Google Scholar 

  57. Householder GT: The role of protein C in congenital and acquired thrombotic disorders. J Oral Maxillofac Surg 46: 781–787, 1988

    PubMed  Google Scholar 

  58. Griffin JH, Evatt B, Zimmerman TSet al.: Deficiency of protein C in congenital thrombotic disease. J Clin Invest 68: 1370–1373, 1981

    PubMed  Google Scholar 

  59. Sawaya R, Ramo OJ, Glas-Greenwalt P, Wu SZ: Plasma fibrinolytic profile in patients with brain tumors. Thrombosis and Haemostasis 65: 15–19, 1991

    PubMed  Google Scholar 

  60. Singh VP, Jain D, Mohan R, Bhatia R, Bhargava: Haemostatic abnormalities in brain tumors. Acta Neurochir (Wien) 102: 103–107, 1990

    Google Scholar 

  61. Sawaya R, Kornblith PL: Brain tumors and thromboembolic complications. Surg Neurol 28: 163, 1987

    PubMed  Google Scholar 

  62. Levi ADO, Wallace MC, Bernstein M, Walters BC: Venous thromboembolism after brain tumor surgery: A retrospective review. Neurosurgery 28: 859–863, 1991

    PubMed  Google Scholar 

  63. Al-mefty O, Holoubi A, Rifai A, Fox JL: Microsurgical removal of suprasellar meningiomas. Neurosurgery 16: 364–372, 1985

    PubMed  Google Scholar 

  64. Al-Mefty O, Fox JL, Smith RR: Petrosal approach for petroclival meningiomas. Neurosurgery 22: 510–517, 1988

    PubMed  Google Scholar 

  65. Kadis GN, Mount LA, Ganti SR: The importance of early diagnosis and treatment of the meningiomas of the planum sphenoidale and tuberculum sellae: A retrospective study of 105 cases. Surg Neurol 12: 367–371, 1979

    PubMed  Google Scholar 

  66. Mayberg MR, Symon L: Meningiomas of the clivus and apical petrous bone. Report of 35 cases. J Neurosurg 65: 160–167, 1986

    PubMed  Google Scholar 

  67. Symon L, Rosenstein J: Surgical management of suprasellar meningioma. Part I: The influence of tumor size, duration of symptoms, and microsurgery on surgical outcome in 101 consecutive cases. J Neurosurg 61: 633–641, 1984

    PubMed  Google Scholar 

  68. Valladares JB, Hankinson J: Incidence of lower extremity deep vein thrombosis in neurosurgical patients. Neurosurgery 6: 138–141, 1980

    PubMed  Google Scholar 

  69. Ruff RL, Posner JB: The incidence of systemic venous thrombosis and the risk of anticoagulation in patients with malignant gliomas. Am Neurol Assoc 106: 223–226, 1981

    Google Scholar 

  70. Brisman R, Mendell J: Thromboembolism and brain tumors. J Neurosurg 38: 337–338, 1973

    PubMed  Google Scholar 

  71. Blabey RG, Weil R III, Santulli TV: Iliofemoral thrombophlebitis associated with central nervous system pathology. Am J Surg 130: 315–316, 1975

    PubMed  Google Scholar 

  72. Sjøberg HE, Blombäck M, Granbert PO: Thromboembolic complications, heparin treatment and increase in coagulation factors in Cushing's syndrome. Acta Med Scand 199: 95–98, 1976

    PubMed  Google Scholar 

  73. Dal Bo Zanon R, Fornasiero L, Boscaro Met al.: Increased factor VIII associated activities in Cushing's syndrome: a probable hypercoagulable state. Thromb Haemostos 47: 116–117, 1985

    Google Scholar 

  74. Patrassi GM, Dal Bo Zanon R, Boscaro M: Further studies on the hypercoagulable state of patients with Cushing's syndrome. Thromb Haemostas 54: 518–520, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

    Raymond E. Sawaya & B. Lee Ligon

Authors
  1. Raymond E. Sawaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Lee Ligon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sawaya, R.E., Lee Ligon, B. Thromboembolic complications associated with brain tumors. J Neuro-Oncol 22, 173–181 (1994). https://doi.org/10.1007/BF01052892

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01052892

Key words

Search

Navigation